Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parotid Neoplasms × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 123 Breast Neoplasms 98 Lung Neoplasms 80 Carcinoma, Non-Small-Cell Lung 71 Neoplasm Metastasis 59 Glioblastoma 56 Brain Neoplasms 56 Glioma 51 Pancreatic Neoplasms 39 Carcinoma, Renal Cell 38 Multiple Myeloma 33 Lymphoma, Large B-Cell, Diffuse 31 Squamous Cell Carcinoma of Head and Neck 30 Melanoma 30 Colorectal Neoplasms 28 Neoplasms 26 Urinary Bladder Neoplasms 25 Carcinoma, Hepatocellular 25 Ovarian Neoplasms 24 Lymphoma 24 Central Nervous System Neoplasms 22 Astrocytoma 22 Oropharyngeal Neoplasms 21 Lymphoma, Follicular 21 Triple Negative Breast Neoplasms 20 Sarcoma 20 Mouth Neoplasms 19 Gliosarcoma 18 Carcinoma 17 Neuroblastoma 16

Interventions

pembrolizumab 1 gadobutrol 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Limonene 1 Erlotinib Hydrochloride 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03950323 2020-04-14

R-PO19053

CHU de Reims

Phase NA Unknown

Facial Paralysis, Parotid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡